SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-May-24 6:17 PM View: | Krystal Biotech, Inc. (KRYS) | 20-May-24 | Option Exercise | 20,000 | $22.75 | $455,000.00 | 100% 0 to 20.0K | |
22-May-24 6:17 PM View: | Krystal Biotech, Inc. (KRYS) | 20-May-24 | Option Sale | 20,000 | $164.13 | $3,282,690.00 | (100%) 20.0K to 0 | |
03-May-24 8:44 AM View: | Revance Therapeutics, Inc. (RVNC) | 01-May-24 | Grant | 15,000 | -- | -- | 50% 30.11K to 45.11K | |
05-May-23 5:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-May-23 | Grant | 3,534 | -- | -- | 13% 26.57K to 30.11K | |
06-May-22 6:18 PM View: | Revance Therapeutics, Inc. (RVNC) | 04-May-22 | Grant | 6,059 | -- | -- | 30% 20.51K to 26.57K | |
07-May-21 7:06 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-May-21 | Grant | 4,013 | -- | -- | 24% 16.5K to 20.51K | |
15-May-20 6:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-May-20 | Grant | 6,000 | -- | -- | 57% 10.5K to 16.5K | |
14-May-19 9:00 PM View: | Gw Pharmaceuticals Plc (GWPH) | 10-May-19 | Option Exercise | 671,928 | $2.26 | $1,517,240.00 | 631% 106.55K to 778.48K | |
14-May-19 9:00 PM View: | Gw Pharmaceuticals Plc (GWPH) | 10-May-19 | Planned Option Sale | 671,928 | $14.84 | $9,973,280.00 | (86%) 778.48K to 106.55K | |
10-May-19 8:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-May-19 | Grant | 4,500 | -- | -- | 75% 6.0K to 10.5K | |
28-Feb-19 5:09 PM View: | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-19 | Option Exercise | 11,256 | $0.00 | $14.63 | 11% 101.29K to 112.55K | |
28-Feb-19 5:09 PM View: | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-19 | Option Sale | 6,000 | $12.45 | $74,696.20 | (5%) 112.55K to 106.55K | |
11-May-18 8:27 PM View: | Revance Therapeutics, Inc. (RVNC) | 10-May-18 | Grant | 3,000 | -- | -- | 100% 3.0K to 6.0K | |
12-May-17 7:48 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-May-17 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
19-Mar-15 7:27 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Grant | 7,892 | -- | -- | 1461% 0.54K to 8.43K | |
19-Mar-15 7:27 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Disposition | 486 | -- | -- | (6%) 8.43K to 7.95K | |
19-Mar-15 7:27 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Disposition | 7,946 | -- | -- | (100%) 7.95K to 0 | |
19-Mar-15 7:27 PM View: | Allergan Inc. (AGN) | 06-Mar-15 | Gift | 20,078 | -- | -- | (88%) 22.71K to 2.63K | |
19-Mar-15 7:27 PM View: | Allergan Inc. (AGN) | 06-Mar-15 | Gift | 2,095 | -- | -- | (80%) 2.63K to 0.54K | |
24-Feb-15 9:44 PM View: | Allergan Inc. (AGN) | 20-Feb-15 | Payment of Exercise | 269 | $234.00 | $62,946.00 | (1%) 22.98K to 22.71K | (1%) |
24-Feb-15 9:44 PM View: | Allergan Inc. (AGN) | 20-Feb-15 | Option Exercise | 514 | -- | -- | 2% 22.47K to 22.98K | |
19-Feb-15 7:35 PM View: | Allergan Inc. (AGN) | 17-Feb-15 | Payment of Exercise | 1,150 | $230.15 | $264,672.00 | (5%) 23.62K to 22.47K | (3%) |
07-Mar-14 8:02 PM View: | Allergan Inc. (AGN) | 06-Mar-14 | Gift | 3,120 | -- | -- | 13% 23.59K to 26.71K | |
07-Mar-14 8:02 PM View: | Allergan Inc. (AGN) | 06-Mar-14 | Gift | 3,120 | -- | -- | (12%) 26.71K to 23.59K | |
25-Feb-14 6:01 PM View: | Allergan Inc. (AGN) | 21-Feb-14 | Payment of Exercise | 1,880 | $125.07 | $235,132.00 | (7%) 25.43K to 23.55K | (90%) |
30-Dec-13 5:18 PM View: | Allergan Inc. (AGN) | 27-Dec-13 | Option Exercise | 52,500 | $53.71 | $2,819,780.00 | 206% 25.43K to 77.93K | |
30-Dec-13 5:18 PM View: | Allergan Inc. (AGN) | 27-Dec-13 | Planned Option Sale | 52,500 | $110.05 | $5,777,550.00 | (67%) 77.93K to 25.43K | (116%) |
04-Mar-13 8:03 PM View: | Allergan Inc. (AGN) | 28-Feb-13 | Gift | 4,301 | -- | -- | 17% 25.39K to 29.69K | |
04-Mar-13 8:03 PM View: | Allergan Inc. (AGN) | 28-Feb-13 | Gift | 4,301 | -- | -- | (14%) 29.69K to 25.39K | |
22-Feb-13 7:30 PM View: | Allergan Inc. (AGN) | 20-Feb-13 | Payment of Exercise | 2,699 | $108.08 | $291,708.00 | (10%) 28.09K to 25.39K | (120%) |
14-Jan-13 7:17 PM View: | Allergan Inc. (AGN) | 11-Jan-13 | Gift | 401 | -- | -- | 1% 28.08K to 28.48K | |
14-Jan-13 7:17 PM View: | Allergan Inc. (AGN) | 11-Jan-13 | Gift | 401 | -- | -- | (1%) 28.48K to 28.08K | |
03-Jan-13 5:41 PM View: | Allergan Inc. (AGN) | 31-Dec-12 | Payment of Exercise | 353 | $91.73 | $32,380.70 | (1%) 28.59K to 28.23K | (40%) |
29-Nov-12 7:55 PM View: | Allergan Inc. (AGN) | 28-Nov-12 | Option Exercise | 55,378 | $58.55 | $3,242,380.00 | 56% 99.6K to 154.97K | |
29-Nov-12 7:55 PM View: | Allergan Inc. (AGN) | 28-Nov-12 | Market Option Sale | 55,378 | $91.66 | $5,075,950.00 | (36%) 154.97K to 99.6K | (40%) |
29-Nov-12 7:55 PM View: | Allergan Inc. (AGN) | 27-Nov-12 | Option Exercise | 34,622 | $42.62 | $1,475,420.00 | 35% 99.6K to 134.22K | |
29-Nov-12 7:55 PM View: | Allergan Inc. (AGN) | 27-Nov-12 | Private Option Sale | 34,622 | $92.25 | $3,193,990.00 | (26%) 134.22K to 99.6K | (158%) |
19-Mar-12 9:50 PM View: | Allergan Inc. (AGN) | 15-Mar-12 | Gift | 345 | -- | -- | 1% 28.41K to 28.76K | |
19-Mar-12 9:50 PM View: | Allergan Inc. (AGN) | 15-Mar-12 | Gift | 345 | -- | -- | (1%) 28.76K to 28.41K | |
24-Feb-12 6:37 PM View: | Allergan Inc. (AGN) | 22-Feb-12 | Payment of Exercise | 157 | $87.27 | $13,701.40 | (< 1%) 28.57K to 28.41K | (54%) |
22-Feb-12 9:11 PM View: | Allergan Inc. (AGN) | 17-Feb-12 | Grant | 323 | -- | -- | 1% 28.25K to 28.57K | |
30-Nov-11 7:17 PM View: | Allergan Inc. (AGN) | 28-Nov-11 | Gift | 11,827 | -- | -- | 42% 28.23K to 40.06K | |
30-Nov-11 7:17 PM View: | Allergan Inc. (AGN) | 28-Nov-11 | Gift | 11,827 | -- | -- | (30%) 40.06K to 28.23K |